Evidence map›Paper›PMID 40149462›Full record

ArticleGenes2025

Identification of a Homozygous Variant in the

Nadia Petrillo, Simone Marcella, Roberto Sirica, Monica Ianniello, Raffaella Ruggiero, Alessio Mori, Rosa Castiello, Cristina Ramiro, Rossana D'Angelo, Giuliano Pennacchio and 4 more

Abstract readCase Reports
In one paragraph

Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nadia PetrilloAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.ORCID 0009-0008-5131-9528
Simone MarcellaAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Roberto SiricaAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Monica IannielloAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Raffaella RuggieroAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Alessio MoriAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Rosa CastielloAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Cristina RamiroAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Rossana D'AngeloAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Giuliano PennacchioCEINGE Biotecnologie Avanzate Franco Salvatore S.c.a.r.l., 80145 Naples, Italy.
Ermanno BarlettaClinica Villa dei Fiori, Acerra, 80011 Naples, Italy.
Roberto PassaroClinica Villa dei Fiori, Acerra, 80011 Naples, Italy.
Antonio FicoAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
Giovanni SavareseAMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.ORCID 0009-0004-5274-3989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesCongenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by mutations in the

methodsWe performed a NIPT, which showed a 46, XX genotype, confirmed by karyotype on the newborn's DNA extracted lymphocytes. For clinical suspicion of CAH, we performed reverse dot blot and Multiple Ligation-dependent Probe Amplification (MLPA) of the

resultsReverse dot blot and MLPA detected the presence of the c.290-13A/C>G (I2 splice) mutation in heterozygosity in the parents and in homozygosity in the child, respectively. NGS detected the c.290-13A/C>G (I2splice) mutation in cell-free fetal DNA (cfDNA) in mother's plasma with a variant allele frequency (VAF) of 67% with a fetal fraction (FF) of 5%. This latter suggests the presence of the variant both in the mother and in newborn cfDNA.

conclusionsThe study reinforces the hypothesis that cfDNA can be used to identify point mutations, small insertions and/or deletions for the diagnosis of monogenic diseases, reducing the number of invasive tests and the risk of early miscarriages. Early detection of mutations in genes causing sexual development disorders could make it possible to start therapy in the womb.

Indexed as

Adrenal Hyperplasia, CongenitalCell-Free Nucleic AcidsSteroid 21-HydroxylaseAdultFemaleHigh-Throughput Nucleotide SequencingHomozygoteHumansInfant, NewbornMaleMutationPregnancyCell-Free Nucleic AcidsCYP21A2 protein, humanSteroid 21-HydroxylaseCAHCfDNACYP21A2hydrocortisoneNGSNIPT

Identifiers

PMID40149462
PMCPMC11941760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.